>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

FDA Limits Acetaminophan in Prescription Combination Products

Monday, January 17, 2011

The U.S. Food and Drug Administration (FDA) is asking manufacturers of prescription products that contain acetaminophen to limit its amount to no more than 325 milligrams. The FDA is requiring each manufacturer to update labels of all prescription combination acetaminophen products to warn of the potential risk for severe liver injury.  Over-the-counter acetaminophen products are not affected by this FDA action.

Acetaminophen is a drug that relieves pain and fever. It is combined in many prescription products with other ingredient, usually opioids.  The reason for this FDA action is because of continued reports of liver injury, though most of the cases of severe liver damage occurred in patients who took more than the prescribed dose.

« Back to Washington Alerts